• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT SYSTEM Back to Search Results
Model Number AVFM10080
Device Problem Obstruction of Flow (2423)
Patient Problem Stenosis (2263)
Event Date 01/30/2018
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiry date: 02/2020).
 
Event Description
It was reported through the results of a clinical trial approximately 9-months post index procedure, 60.3% target lesion stenosis and standard pta was performed to treat lesion.It was further reported approximately 2 years post index procedure 70% stenosis was identified and standard pta was performed to treat lesion.The current patient status is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a review of manufacturing records was not performed, as additional complaints have not been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: a physical sample was not available for evaluation, and images have not been provided; the alleged stenosis could not be re produced which led to an inconclusive evaluation result.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling for this product, it was found that the instructions for use sufficiently address the potential issue.Regarding pre- and post- dilation, the instruction for use states: 'pre-dilate the stenosis with a pta balloon catheter of appropriate length and diameter for the lesion to be treated' and 'post dilate the covered stent with an angioplasty balloon sized appropriately as to ensure complete wall apposition to the reference vessel.' the ifu further state 'potential complications may include, but are not limited to: thrombotic occlusion, restenosis requiring reintervention'.Holding and handling of the system throughout deployment was found sufficiently described.H10: d4 (expiry date: 02/2020).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the results of a clinical trial approximately nine months post index procedure, 60.3% target lesion stenosis and standard pta was performed to treat lesion.It was further reported approximately two years post index procedure 70% stenosis was identified and standard pta was performed to treat lesion.The current patient status is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVERA VASCULAR COVERED STENT SYSTEM
Type of Device
VASCULAR COVERED STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key9789021
MDR Text Key182334708
Report Number9681442-2020-00058
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741106606
UDI-Public(01)00801741106606
Combination Product (y/n)N
PMA/PMN Number
P170042
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup
Report Date 09/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAVFM10080
Device Catalogue NumberAVFM10080
Device Lot NumberANAZ3648
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/21/2020
Initial Date FDA Received03/04/2020
Supplement Dates Manufacturer Received08/20/2021
Supplement Dates FDA Received09/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CLOPIDOGREL; CLOPIDOGREL; ELIQUIS; ELIQUIS; OTHER ANTIPLATELET/ ANTITHROMBOTIC/ANTICOAGULANT; OTHER ANTIPLATELET/ ANTITHROMBOTIC/ANTICOAGULANT
Patient Outcome(s) Required Intervention;
Patient Age86 YR
Patient Weight80
-
-